Cardosa; Mary Jane

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cardosa; Mary Jane.The latest application filed is for "expression cassettes and methods for obtaining enterovirus virus-like particles".

Company Profile

6.13.16

Cardosa; Mary Jane - Penang MY
Cardosa; Mary Jane - Georgetown MY
Cardosa; Mary Jane - Kuala Lumpur MY
Cardosa; Mary Jane - Kuching MY
Cardosa; Mary Jane - Kuching Sarawak MY
Cardosa; Mary Jane - Sarawak MY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for producing virus like particles Grant 11,154,614 - Cardosa , et al. October 26, 2	2021-10-26
Antibodies specific for enteroviruses that infect humans Grant 10,822,397 - Cardosa November 3, 2	2020-11-03
Antigens and vaccines directed against human enteroviruses Grant 10,555,997 - Cardosa , et al. Feb	2020-02-11
Antigens and vaccines directed against human enteroviruses Grant 10,548,964 - Cardosa , et al. Fe	2020-02-04
Expression Cassettes And Methods For Obtaining Enterovirus Virus-like Particles App 20190247488 - CARDOSA; Mary Jane	2019-08-15
Chimeric Enterovirus Virus-like Particles App 20190224304 - CARDOSA; Mary Jane	2019-07-25
Improved Method For Producing Virus Like Particles App 20190125862 - CARDOSA; Mary Jane ; et al.	2019-05-02
Antibodies Specific For Enteroviruses That Infect Humans App 20190100574 - Cardosa; Mary Jane	2019-04-04
Antibodies specific for enteroviruses that infect humans Grant 10,125,187 - Cardosa November 13, 2	2018-11-13
Antigens And Vaccines Directed Against Human Enteroviruses App 20180271971 - CARDOSA; Mary Jane ; et al.	2018-09-27
Antigens And Vaccines Directed Against Human Enteroviruses App 20180243400 - CARDOSA; Mary Jane ; et al.	2018-08-30
Antigens and vaccines directed against human enteroviruses Grant 9,987,350 - Cardosa , et al. June 5, 2	2018-06-05
Antibodies Specific For Enteroviruses That Infect Humans App 20160333075 - Cardosa; Mary Jane	2016-11-17
Antigens and Vaccines Directed Against Human Enteroviruses App 20150140027 - Cardosa; Mary Jane ; et al.	2015-05-21
Antigens and Vaccines Directed Against Human Enteroviruses App 20150056244 - Cardosa; Mary Jane ; et al.	2015-02-26
Flavivirus NS1 subunit vaccine Grant 8,815,501 - Howley , et al. August 26, 2	2014-08-26
Allergenic proteins of natural rubber latex, their production and use in assays Grant 7,994,288 - Cardosa , et al. August 9, 2	2011-08-09
MVA virus vector expressing dengue NS1 protein Grant 7,759,116 - Howley , et al. July 20, 2	2010-07-20
Flavivirus Ns1 Subunit Vaccine App 20100136054 - Howley; Paul ; et al.	2010-06-03
Flavivirus Ns1 Subunit Vaccine App 20100047280 - Howley; Paul ; et al.	2010-02-25
Allergenic proteins of natural rubber latex, their production and use in assays App 20090285859 - Cardosa; Mary Jane ; et al.	2009-11-19
Allergenic proteins of natural rubber latex, their production and use in assays Grant 7,576,184 - Cardosa , et al. August 18, 2	2009-08-18
Flavivirus ns1 subunit vaccine App 20060159699 - Howley; Paul ; et al.	2006-07-20
Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines Grant 6,869,793 - Cardosa , et al. March 22, 2	2005-03-22
Allergenic proteins of natural rubber latex, their production and use in assays App 20050043518 - Cardosa, Mary Jane ; et al.	2005-02-24
Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines App 20040265324 - Cardosa, Mary Jane ; et al.	2004-12-30
Allergenic proteins of natural rubber latex, their production and use in assays Grant 6,759,517 - Cardosa , et al. July 6, 2	2004-07-06
Recombinant Mva Virus Expressing Dengue Virus Antigens, And The Use Thereof In Vaccines App 20030082205 - CARDOSA, MARY JANE ; et al.	2003-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.